tiprankstipranks
Trending News
More News >
Teva Pharmaceutical Industries Limited (DE:TEV)
NYSE:TEV
Germany Market

Teva Pharmaceutical (TEV) Cash flow

Compare
36 Followers

Teva Pharmaceutical Cash Flow

DE:TEV's free cash flow for Q4 2025 was $1.02B. For the 2025 fiscal year, DE:TEV's free cash flow was decreased by $399.00M and operating cash flow was $1.16B. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ 1.65B$ 1.25B$ 1.37B$ 1.59B$ 798.00M
Investing Cash Flow
$ 737.00M$ 792.00M$ 968.00M$ 656.00M$ 1.52B
Financing Cash Flow
$ -2.15B$ -1.79B$ -1.91B$ -1.49B$ -2.17B
End Cash Position
$ 3.56B$ 3.30B$ 3.23B$ 2.83B$ 2.20B
Free Cash Flow
$ 1.15B$ 749.00M$ 842.00M$ 1.04B$ 236.00M
Currency in USD

Teva Pharmaceutical Cash Flow